NOGRA PHARMA

Serial Number 85938561
Registration 4504417
710

Registration Progress

Application Filed
May 21, 2013
Under Examination
Approved for Publication
Jan 14, 2014
Published for Opposition
Jan 14, 2014
Registered
Apr 1, 2014

Trademark Image

NOGRA PHARMA

Basic Information

Serial Number
85938561
Registration Number
4504417
Filing Date
May 21, 2013
Registration Date
April 1, 2014
Published for Opposition
January 14, 2014
Cancellation Date
November 4, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Nov 4, 2020

Rights Holder

Nogra Pharma Limited

99
Address
33 Sir John Rogerson's Quay
Dublin 2
IE

Ownership History

Nogra Pharma Limited

Original Applicant
99
Dublin 2 IE

Nogra Pharma Limited

Owner at Publication
99
Dublin 2 IE

Nogra Pharma Limited

Original Registrant
99
Dublin 2 IE

Legal Representation

Attorney
Laura R. Wanek

USPTO Deadlines

Next Deadline
3184 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-04-01)
Due Date
April 01, 2034
Grace Period Ends
October 01, 2034

Application History

23 events
Date Code Type Description
Nov 5, 2020 NCS8 E NOTICE OF CANCELLATION SEC. 8 EMAILED
Nov 4, 2020 C8.. O CANCELLED SEC. 8 (6-YR)
May 2, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 2, 2020 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Mar 10, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED
Apr 1, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 1, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 14, 2014 PUBO A PUBLISHED FOR OPPOSITION
Jan 14, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 25, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 3, 2013 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2013 DMCC I DATA MODIFICATION COMPLETED
Nov 8, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2013 ALIE A ASSIGNED TO LIE
Oct 30, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2013 CNRT R NON-FINAL ACTION WRITTEN
Sep 13, 2013 GNRT F NON-FINAL ACTION E-MAILED
Sep 13, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2013 DOCK D ASSIGNED TO EXAMINER
Jun 1, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2013 NWAP I NEW APPLICATION ENTERED

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO